Tenaya Therapeutics, Inc.

Return to Grants

Total Awards:
2
Award Value:
$9,017,000
Institution type:
For profit
Short Name:
Tenaya Therapeutics, Inc.

Awards to the Institution

Program Type Investigator Grant Title Award Value
Quest – Discovery Stage Research Projects Karl N Doerner Cardiac Reprogramming Gene Therapy for Post-Myocardial Infarction Heart Failure $1,017,000
Clinical Trial Stage Projects Dr. Matthew Pollman Phase 1b Study of TN-401 in Adults with PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) $8,000,000
Total:
$9,017,000.00